2. Souers,
A. J.; Leverson, J. D.; Boghaert, E. R.; Ackler, S. L.; Catron, N. D.;
Chen, J.; Dayton, B. D.; Ding, H.; Enschede, S. H.; Fairbrother, W. J.;
et al. ABT-199, a potent and selective BCL-2 inhibitor, achieves
antitumor activity while sparing platelets. Nat. Med. 2013, 19, 202–208.3. Kiss,
L. E.; Ferreira, H. S.; Torrão, L.; Bonifacio, M. J.; Palma, P. N.;
Soares-da-Silva, P.; Learmonth, D. A. Discovery of a Long-Acting,
Peripherally Selective Inhibitor of Catechol-O-methyltransferase. J.
Med. Chem. 2010, 53, 3396–3411. 4. Edwards,
D. I. Nitroimidazole drugs - action and resistance mechanisms. I.
Mechanisms of action. J. Antimicrob. Chemother. 1993, 31, 9–20. 5. Rosenkranz,
H. S.; Mermelstein, R. Mutagenicity and genotoxicity of nitroarenes:
All nitro-containing chemicals were not created equal. Mutat. Res., Rev.
Genet. Toxicol. 1983, 114, 217−267.6. Singh,
P. K.; Negi, A.; Gupta, P. K.; Chauhan, M.; Kumar, R. Toxicophore
exploration as a screening technology for drug design and discovery:
Techniques, scope and limitations. Arch. Toxicol. 2016, 90, 1785−1802.7. Li,
F.; Chordia, M. D.; Huang, T.; Macdonald, T. L. In vitro nimesulide
studies toward understanding idiosyncratic hepatotoxicity:
diiminoquinone formation and conjugation. Chem. Res. Toxicol. 2009,
22, 72–80.8. Zhou,
L.; Pang, X.; Xie, C.; Zhong, D.; Chen, X. Reduction of Aromatic and
Heterocyclic Aromatic N-Hydroxylamines by Human Cytochrome P450 2S1.
Chem. Res. Toxicol. 2015, 28, 2267–2277.
还木有评论哦,快来抢沙发吧~